Topological Characterization of the Multi-feature based Network in Patients with Alzheimer's Disease and Mild Cognitive Impairment

被引:0
|
作者
Zheng, Weihao [1 ]
Liu, Tingting [1 ]
Li, Haotian [1 ]
Wu, Dan [1 ]
机构
[1] Zhejiang Univ, Coll Biomed Engn & Instrument Sci, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
multi-feature based network (MFN); Alzheimer's disease (AD); mild cognitive impairment (MCI); topological organization; GRAY-MATTER LOSS; CORTICAL THICKNESS; HUMAN BRAIN; DYNAMICS; PATTERNS; ATROPHY;
D O I
暂无
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Characterization of morphological organization pattern in individual brain has long been an open question. Recently, a novel single-subject network that built upon multiple morphological features (MFN) was introduced [1], which exhibited extraordinary power in diagnosing patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). This study aims to characterize the cortico-cortical topological organization in MCI and AD cohorts via the MFN, and uncover the structural substrate that leads to the high classification accuracy. The MFNs were constructed for 165 normal controls (NCs), 221 patients with MCI, and 142 patients with AD from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Results from graph theoretical analysis showed 'small-world' property and modular organization of the MFN in three groups; as well as increased local clustering and characteristic path length, and altered hub regions in patients with AD and MCI. More importantly, we found the primary atrophic regions were accompanied by increased number of in-flow connections; whereas, the connections that linked to the less atrophic regions were mostly out-flow connections. This phenomenon, we speculated, might indirectly reflect the trophic supporting effects in the brain. Our results demonstrated the basic organizational principles of the MFN and its changes in patients with AD and MCI, providing important implications of what makes the MFN powerful in auto-diagnosis of mental disorders.
引用
收藏
页码:1162 / 1167
页数:6
相关论文
共 50 条
  • [31] Mild cognitive impairment and preclinical Alzheimer's disease
    Morris, JC
    GERIATRICS-US, 2005, : 9 - 14
  • [32] The fornix in mild cognitive impairment and Alzheimer's disease
    Nowrangi, Milap A.
    Rosenberg, Paul B.
    FRONTIERS IN AGING NEUROSCIENCE, 2015, 7
  • [33] Dysgraphia in Alzheimer's disease with mild cognitive impairment
    Kavrie, S
    Neils-Strunjas, J
    JOURNAL OF MEDICAL SPEECH-LANGUAGE PATHOLOGY, 2002, 10 (01) : 73 - 85
  • [34] Aging, mild cognitive impairment, and Alzheimer's disease
    Petersen, RC
    NEUROLOGIC CLINICS, 2000, 18 (04) : 789 - +
  • [35] Mild cognitive impairment: Aging to Alzheimer's disease
    Price, CC
    McCoy, KJM
    CLINICAL NEUROPSYCHOLOGIST, 2004, 18 (02): : 204 - 207
  • [36] Neuropathology of Alzheimer's disease and mild cognitive impairment
    López, OL
    DeKosky, ST
    REVISTA DE NEUROLOGIA, 2003, 37 (02) : 155 - 163
  • [37] Galantamine for Alzheimer's disease and mild cognitive impairment
    Loy, C
    Schneider, L
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [38] MRI in Alzheimer's disease and mild cognitive impairment
    Jack, CR
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 4S - 4S
  • [39] Taste in mild cognitive impairment and Alzheimer's disease
    Steinbach, Silke
    Hundt, Walter
    Vaitl, Andreas
    Heinrich, Petra
    Foerster, Stefan
    Buerger, Katharina
    Zahnert, Thomas
    JOURNAL OF NEUROLOGY, 2010, 257 (02) : 238 - 246
  • [40] Biomarkers of mild cognitive impairment and Alzheimer's disease
    Tang, Bor Luen
    Kumar, Rajeev
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2008, 37 (05) : 406 - 410